(Q84611960)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668427%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668427%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668427%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Charles S Eby

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668427%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Mitchell G Scott

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668427%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Daniel W Coyne

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668427%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

language of work or name

English

0 references

publication date

28 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668427%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668427%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

78

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668427%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668427%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

769-773

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668427%20AND%20SRC:MED&resulttype=core&format=json

Correction of anemia with epoetin alfa in chronic kidney disease

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.254

7 January 2021

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.254

7 January 2021

Baseline Characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.254

7 January 2021

Variability of ferritin measurements in chronic kidney disease; implications for iron management.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.254

7 January 2021

The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.254

7 January 2021

Hepcidin in anemia and inflammation in chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.254

7 January 2021

Is hepcidin the star player in iron metabolism in chronic kidney disease?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.254

7 January 2021

Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.254

7 January 2021

Immunoassay for human serum hepcidin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.254

7 January 2021

Hepcidin--a potential novel biomarker for iron status in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.254

7 January 2021

Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.254

7 January 2021

IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.254

7 January 2021

The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.254

7 January 2021

Serum prohepcidin and hepcidin in hemodialyzed patients undergoing iron therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.254

7 January 2021

Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.254

7 January 2021

Novel urine hepcidin assay by mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.254

7 January 2021

Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.254

7 January 2021

SELDI-TOF-MS determination of hepcidin in clinical samples using stable isotope labelled hepcidin as an internal standard

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.254

7 January 2021

Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.254

7 January 2021

Response to ‘Hepcidin levels in patients with renal disease’

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.254

7 January 2021

High-sensitive radioimmunoassay for human serum hepcidin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.254

7 January 2021

Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.254

7 January 2021

A novel immunological assay for hepcidin quantification in human serum

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.254

7 January 2021

Reduction of serum hepcidin by hemodialysis in pediatric and adult patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.254

7 January 2021